Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Merisant is a global leader in the manufacturing and marketing of tabletop sweeteners and sugar substitutes, providing low-calorie alternatives for health-conscious consumers. The company manages a portfolio of iconic brands, including Equal, Canderel, Pure Via, and Whole Earth, which are sold in over 90 countries. Founded in 2000 through the acquisition of Monsanto's sweetener business, Merisant has expanded its expertise from synthetic sweeteners like aspartame to natural, plant-based options such as stevia and monk fruit. The company's products are integral to the nutritional management of metabolic conditions like diabetes and obesity by helping consumers reduce sugar intake. Merisant operates as a primary subsidiary of Whole Earth Brands, following a 2020 merger that consolidated its position in the global ingredients and consumer health market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Merisant Worldwide.